Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HOWL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
HOWL
Werewolf Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
HOWL
Werewolf Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only HOWL
5
—
Piper Sandler
unlisted
supplier
—
Harpoon
unlisted
supplier
—
Harpoon Therapeutics
unlisted
supplier
—
Adimab
unlisted
supplier
1 more · HOWL chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
HOWL
Werewolf Therapeutics, Inc.
Change
1.00
▼
−2.00%
Mkt cap
$53.0M
Revenue
$21M
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,370.43
▲
+0.42%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
HOWL
Werewolf Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
1.00
▼
−2.00%
Price
1,370.43
▲
+0.42%
$53.0M
Mkt cap
$1.2T
Q2 FY26
$21M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
HOWL
1.00
▼
−2.00%
vs
LLY
1,370.43
▲
+0.42%
Regular session
Nov 6 '26